Written question asked by Lord Mendelsohn (Labour) on Thursday, 27 November 2025, in the House of Lords. It was due for an answer on Thursday, 11 December 2025. It was answered by Baroness Merron (Labour) on Thursday, 4 December 2025 on behalf of the Department of Health and Social Care.
Immunotherapy: Clinical Trials
- Question
-
To ask His Majesty's Government whether they have carried out an impact assessment on the effect of halted CAR-T clinical trials, and whether they will publish that assessment.
- Answer
-
The Department is committed to turbocharging clinical research and ensuring that all patients, including those with cancer, have access to cutting-edge clinical trials and innovative, lifesaving treatments.
The Department has not carried out an impact assessment on the effect of halted CAR-T clinical trials. This is because decisions about whether a specific clinical trial should progress or not are the responsibility of the study sponsor and research team involved, who closely monitor any reported patient safety concerns and other data that could impact this decision.
Secondary information
- Type
- Written question
- Reference
- HL12430
- Session
- 2024-26
- Subjects
- Impact assessments Clinical trials Immunotherapy
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-12-04 11:24:13 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-26/HL12430
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-26/HL12430
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2024-26/HL12430